**Core Concept:**
In post-thyroidectomy management, a whole-body iodine scan (WBS) is a nuclear medicine imaging technique used to detect remnant thyroid tissue or possible recurrent thyroid cancer. WBS relies on the uptake and accumulation of radioactive iodine (I-131) by the thyroid tissue. Differentiated thyroid cancers (DTCs) are typically iodine-avid, meaning they take up radioactive iodine. However, there are specific types of thyroid cancer for which WBS is not indicated.

**Why the Correct Answer is Right:**
A whole-body iodine scan is not recommended for **indolent (slow-growing)** thyroid cancer variants, as they are typically non-iodine-avid, meaning they do not take up radioactive iodine. These cancers grow slowly, are often indolent in nature, and do not show significant radioiodine uptake.

**Why Each Wrong Option is Incorrect:**

A. **Well-differentiated thyroid cancer (e.g., papillary and follicular cancers):** These are iodine-avid and WBS is generally indicated for their surveillance.

B. **Anaplastic thyroid cancer:** Though rare, some anaplastic thyroid cancers can show radioiodine uptake, but they are highly aggressive and have poor prognosis regardless of radioiodine therapy.

C. **Medullary thyroid carcinoma (MTC):** MTC is a type of thyroid cancer originating from parafollicular C cells. While some MTCs may show radioiodine uptake, the majority do not, making WBS unnecessary for surveillance.

D. **Hemangiopericytoma:** Hemangiopericytoma is a rare benign tumor that arises from perivascular cells and is unrelated to the thyroid gland. WBS is not relevant for this non-thyroid condition.

**Clinical Pearl:**
In the context of post-thyroidectomy management, it is essential to differentiate between iodine-avid and non-avid thyroid cancers to guide appropriate diagnostic and therapeutic strategies. WBS is routinely used for monitoring differentiated thyroid cancers (A), while non-avid cancers (B, C, D) require different diagnostic or surveillance modalities.

The provided question tests our understanding of the thyroid cancer subtypes and their iodine avidity, which is crucial for proper management and patient care.